An Intervention Program to Control Diabetes

This study has been completed.
Sponsor:
Information provided by:
Abbott Nutrition
ClinicalTrials.gov Identifier:
NCT00543621
First received: October 12, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted

October 12, 2007
October 12, 2007
May 2005
Not Provided
HbA1c, Fasting blood glucose,blood pressure, weight loss [ Time Frame: 24 weeks ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
An Intervention Program to Control Diabetes
An Intervention Program to Control Diabetes

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Diabetes Mellitus, Type 2
Other: daily enteral nutritional product and/or behavioral changes
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
Not Provided
Not Provided

Inclusion Criteria:

  • informed consent
  • 18-70 adults
  • Type 2 Diabetes
  • Males and non-pregnant females

Exclusion Criteria:

  • Use of exogenous insulin for glucose control
  • Use of medications or supplements for weight loss
  • Advanced diabetes complications
  • Recent history of cardiovascular event
Both
18 Years to 70 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
China
 
NCT00543621
Welltech Study
No
Not Provided
Abbott Nutrition
Not Provided
Principal Investigator: Jianqin Sun, MD, MPH Clinical Nutrition Center, Huadong Hospital
Abbott Nutrition
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP